Intarcia Therapeutics Receives $215,000,000 New Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=633b6c8b-39f2-4de6-970c-62bcac7b39c1
Date
9/16/2016
Company Name
Intarcia Therapeutics
Mailing Address
155 Seaport Boulevard 11th Floor Boston, MA 02210 USA
Company Description
Intarcia Therapeutics, Inc., is a rapidly emerging biopharmaceutical company committed to developing innovative therapies that merge medicine with technology, and have the potential to transform therapeutic categories.
Website
http://www.intarcia.com
Transaction Type
Venture Equity
Transaction Amount
$215,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed.
M&A Terms
Venture Investor
Undisclosed